All news from Anaesthesiology

'E-dermis': New Technology To Bring Sense of Touch, Pain to Prosthetic Hands

Amputees often experience the sensation of a "phantom limb" — a feeling that a missing body part is still there. That sensory illusion is closer to becoming a reality thanks to a team of engineers at the Johns Hopkins University that has created an electronic skin. When layered on top of prosthetic hands, this e-dermis brings back a real sense of touch through the fingertips.

Role of Viperin Against Virus Replication

A team of researchers has identified the mode of action of viperin, a naturally occurring enzyme in humans and other mammals that is known to have antiviral effects on viruses such as West Nile, hepatitis C, rabies, and HIV. This discovery could allow researchers to develop a drug that could act as a broad-spectrum therapy for a range of viruses, including Zika.

Computational Geeks Uncovered a Therapy for Cancer

It's called the 'kiss of death'. Triple-negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple-negative breast cancer is aggressive and deadly. Patients are currently treated by chemotherapy but there is no guarantee of success—and unfortunately, for those that chemotherapy does not work, the survival rate remains only 12 months.

Role of Bacteriophages in Parkinson's Disease

In the first study of its kind, researchers from the New York-based Human Microbiology Institute have discovered the role certain bacteriophages may play in the onset of Parkinson's disease (PD). The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology, held from June 7th to June 11th in Atlanta, Georgia.

Cancer Cells Can Be Dead By Blocking Two Enzymes

Scientists have identified two enzymes that protect chromosomes from oxidative damage and shortening. Blocking them might be a new anticancer strategy for stopping telomerase, the enzyme that immortalizes tumors. Before cell division, the long strings of the cell's DNA are wrapped tightly into the structures we know as chromosomes. This protects the cell's genetic material from physical and chemical damage.

Tranexamic Acid For Hyperacute Primary IntraCerebral Haemorrhage

A randomized study determines Tranexamic acid for intracranial hemorrhage failed to significantly improve functional status compared with placebo at 90 days. However, the antifibrinolytic agent was associated with a decrease in deaths in the first week and attenuation of hematoma expansion.

The primary outcome of the phase 3 Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2). The study was published in The Lancet.